Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Hemodynamic Stability in Laparoscopic Surgery
ChiCTR2500109128Phase 4Not yet recruiting
- Sponsor
- Changzhou Cancer Hospital of Soochow University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (3 arms), sponsored by Changzhou Cancer Hospital of Soochow University. Primary endpoint: Cardiac Index. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2500109128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109128.